Product Images Amlodipine Besylate 5 Mg

This is a description of a medication called Amlodipine besylate, which comes in the form of tablets. Each tablet contains 2.5 mg of Amlodipine besylate. The dosage and usage information are included in the package insert. The medicine should be dispensed in containers that are light-resistant and tightly closed. The tablets should be stored between 20°C and 25°C and protected from light. The medication is marketed and packaged by PD-Rx Pharmaceuticals, Inc. The manufacturer of the medication is Oxford Pharmaceuticals, LLC located in Birmingham, Alabama.*

Each tablet contains 5 mg of amlodipine besylate. Marketed and packaged by PD-Rx Pharmaceuticals, Inc. The dosage and use information can be found in the package insert. These tablets are dispensed in light-resistant containers and should be stored at a temperature of 20-25°C. Manufactured by BESy'flE Oxford Pharmaceuticals, LLC in Birmingham, Alabama. This package contains 90 tablets with an expiration date of 09/2023 and a unique identifier number.*

Amlodipine besylate tablets used for treating high blood pressure. Each tablet contains 10 mg amlodipine. Dosage information is provided in the package insert. The tablets are dispensed in tight light-resistant containers, stored at 20° to 25°C (68° to 77°F), and protected from light. The tablets are packaged in a bottle of 1000 tablets and marketed by PD-Rx Pharmaceuticals, Inc. They are manufactured by Oxford Pharmaceuticals, LLC. The product has an NDC code of 72789-262-95, a GTIN of 00372789262956, and an expiry date of 09/2023 with LOT number Z99Z99.*

This appears to be a statistical report on an event rate. The report includes a p-value of 0.003 and a hazard ratio of 0.691 with a 95% confidence interval between 0.54 and 0.88 for a placebo. The report also mentions "Amlodipine" but it's unclear what the relevance of this is. Time is measured in months.*

This text provides detailed information on the demographic and baseline characteristics of a group of patients involved in a clinical study. It includes data on age, gender, baseline sitting systolic blood pressure, vessel disease, vessels with stenosis, and PCl-stent strata. Additionally, it includes information on the number of participants in each subgroup. There is a comparison of Amlodipine versus Placebo using Hazard Ratio (95% Confidence Interval).*